中文BIGBEAR Pharmaceutical announces the approval of Binimetinib and Encorafenib in Laos
Vientiane, Laos - October 12 2024 - BigBear Pharma, a leading biopharmaceutical
BIGBEAR Pharmaceutical announces the approval of Lusutrombopag in Laos
Vientiane, Laos - August 08 2024 - BigBear Pharma, a leading biopharmaceutical c
BIGBEAR Pharmaceutical announces the approval of Letermovir and Olaparib in Laos
Vientiane, Laos - September 20, 2024 - BigBear Pharma, a leading biopharmaceutic
BIGBEAR Pharmaceutical announces the approval of Pralsetinib in Laos
Vientiane, Laos - August 12 2024 - BigBear Pharma, a leading biopharmaceutical c
BIGBEAR Pharmaceutical announces the approval of TAZEMETOSTAT in Laos
Vientiane, Laos - August 01 2024 - BigBear Pharma, a leading biopharmaceutical c
BIGBEAR Pharmaceutical announces the approval of Adagrasib in Laos
Vientiane, Laos - July 14, 2024 - BigBear Pharma, a leading biopharmaceutical co
BIGBEAR Pharmaceutical announces the approval of Larotrectinib in Laos
Vientiane, Laos - May 30, 2024 - BigBear Pharma, a leading biopharmaceutical com
BIGBEAR Pharmaceutical announces the approval of baricitinib and selumetinib in Laos
Vientiane, Laos - April 8, 2024 - BigBear Pharma, a leading biopharmaceutical co
Big Bear Pharmaceutical Announces Trelagliptin and Ivosidenib Approved in Laos
Laos Vientiane-January 03, 2024-BigBear Pharma, a leading alchemon company focus
Big Bear Pharmaceutical Announces Selpercatinib Entrectinib and Enasidenib Approved in Laos
Laos Vientiane-October 11, 2023-BigBear Pharma, a leading alchemon company focus